All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Synucleinopathies and their laboratory bio markers

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F21%3AA2202CPI" target="_blank" >RIV/61988987:17110/21:A2202CPI - isvavai.cz</a>

  • Result on the web

    <a href="https://www.csnn.eu/casopisy/ceska-slovenska-neurologie/2021-6-7/synukleinopatie-a-jejich-laboratorni-bio-markery-129374" target="_blank" >https://www.csnn.eu/casopisy/ceska-slovenska-neurologie/2021-6-7/synukleinopatie-a-jejich-laboratorni-bio-markery-129374</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.48095/cccsnn2021535" target="_blank" >10.48095/cccsnn2021535</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Synucleinopathies and their laboratory bio markers

  • Original language description

    Neurodegenerative diseases represent a large and heterogeneous group of disorders. Their common feature is the deposition of a certain pathological protein in brain tissue. The location and distribution of abnormally constituted alpha-synuclein deposits in central and peripheral nervous system define each respective disorder. The location and distribution of a-synuclein deposits define each respective disorder. Synucleinopathies currently include Parkinson's disease, Parkinson's disease with dementia, Lewy body dementia, multiple system atrophy, pure autonomic failure, and idiopathic REM sleep disorder. The detection of a-synuclein alone in these diseases has the effect in differentiating them from other neurodegenerative diseases; however, its specificity in the differential dia gnosis of individual synucleinopathies is relatively low. Therefore, it is necessary to look for other dia gnostic bio markers that would contribute to the early and accurate dia gnosis of individual diseases. At the same time, it is not just a matter of looking for new markers, but also of looking for more available bio logical samples or body fluids in which these bio markers can be eff ectively detected. In the introduction of this review there is a brief description of each disorder and subsequently there is a brief overview of mostly diagnostic laboratory biomarkers. We first present the cerebrospinal fl uid bio markers that refl ect the direct neuropathological changes, and then several bio markers found in peripheral tissues.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30103 - Neurosciences (including psychophysiology)

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE

  • ISSN

    1210-7859

  • e-ISSN

    1802-4041

  • Volume of the periodical

    84

  • Issue of the periodical within the volume

    6

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    5

  • Pages from-to

    535-539

  • UT code for WoS article

    000748805900001

  • EID of the result in the Scopus database